- Drug Pipelines
- April 2024
- 230 Pages
Global
From €2863EUR$3,000USD£2,399GBP
- Report
- July 2022
- 63 Pages
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- May 2022
- 80 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- May 2022
- 47 Pages
Global
From €2386EUR$2,500USD£1,999GBP
The Adenosine Receptor market is a key component of the drug discovery process. Adenosine receptors are proteins found in the cell membrane that bind to adenosine, a nucleoside found in all living cells. Adenosine receptors are involved in a variety of physiological processes, including the regulation of blood pressure, heart rate, and sleep. As such, they are a target for drug discovery, as drugs that target these receptors can be used to treat a variety of conditions.
The Adenosine Receptor market is highly competitive, with a number of companies developing drugs that target these receptors. Companies such as AstraZeneca, GlaxoSmithKline, Merck, and Pfizer are all involved in the development of drugs that target adenosine receptors. Additionally, a number of smaller companies are also involved in the development of drugs that target these receptors. Show Less Read more